CN104000934B - 一种低溶点灌肠咖啡组合物 - Google Patents
一种低溶点灌肠咖啡组合物 Download PDFInfo
- Publication number
- CN104000934B CN104000934B CN201410237818.5A CN201410237818A CN104000934B CN 104000934 B CN104000934 B CN 104000934B CN 201410237818 A CN201410237818 A CN 201410237818A CN 104000934 B CN104000934 B CN 104000934B
- Authority
- CN
- China
- Prior art keywords
- coffee
- lmp
- coloclysis
- radix
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013353 coffee beverage Nutrition 0.000 title claims abstract description 49
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 239000000284 extract Substances 0.000 claims abstract description 19
- 241000628997 Flos Species 0.000 claims abstract description 18
- 210000000582 semen Anatomy 0.000 claims abstract description 8
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims abstract description 8
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 235000021539 instant coffee Nutrition 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 18
- 241000792859 Enema Species 0.000 abstract description 15
- 239000007920 enema Substances 0.000 abstract description 15
- 229940095399 enema Drugs 0.000 abstract description 15
- 230000000968 intestinal effect Effects 0.000 abstract description 15
- 231100000614 poison Toxicity 0.000 abstract description 13
- 230000001737 promoting effect Effects 0.000 abstract description 13
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract description 10
- 210000004185 liver Anatomy 0.000 abstract description 8
- 230000008569 process Effects 0.000 abstract description 8
- 239000002574 poison Substances 0.000 abstract description 7
- 239000007788 liquid Substances 0.000 abstract description 6
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 abstract description 6
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract description 5
- 229960001948 caffeine Drugs 0.000 abstract description 5
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract description 5
- 210000000936 intestine Anatomy 0.000 abstract description 5
- 235000020564 organic coffee Nutrition 0.000 abstract description 4
- 241000533293 Sesbania emerus Species 0.000 abstract description 3
- 238000001816 cooling Methods 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 229960000278 theophylline Drugs 0.000 abstract description 3
- 230000000994 depressogenic effect Effects 0.000 abstract description 2
- 230000035622 drinking Effects 0.000 abstract description 2
- 239000000686 essence Substances 0.000 abstract description 2
- 210000000232 gallbladder Anatomy 0.000 abstract description 2
- 230000000144 pharmacologic effect Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 29
- 230000013872 defecation Effects 0.000 description 22
- 201000010099 disease Diseases 0.000 description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 18
- 239000003053 toxin Substances 0.000 description 13
- 231100000765 toxin Toxicity 0.000 description 13
- 239000003814 drug Substances 0.000 description 11
- 206010010774 Constipation Diseases 0.000 description 10
- 210000002429 large intestine Anatomy 0.000 description 10
- 238000010926 purge Methods 0.000 description 10
- 238000002560 therapeutic procedure Methods 0.000 description 10
- 230000001717 pathogenic effect Effects 0.000 description 8
- 241001070941 Castanea Species 0.000 description 6
- 235000014036 Castanea Nutrition 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000019790 abdominal distention Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000002440 hepatic effect Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 208000004930 Fatty Liver Diseases 0.000 description 4
- 206010019708 Hepatic steatosis Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 206010061428 decreased appetite Diseases 0.000 description 4
- 208000010706 fatty liver disease Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 231100000240 steatosis hepatitis Toxicity 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- ZFMSMUAANRJZFM-UHFFFAOYSA-N Estragole Chemical compound COC1=CC=C(CC=C)C=C1 ZFMSMUAANRJZFM-UHFFFAOYSA-N 0.000 description 2
- 206010056325 Faecaloma Diseases 0.000 description 2
- 206010016807 Fluid retention Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000035568 catharsis Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 238000012858 packaging process Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- MVMVVEIJWOKMLH-UHFFFAOYSA-N 1-methoxy-4-prop-2-enylbenzene;2-methyl-4-prop-2-enylphenol Chemical compound COC1=CC=C(CC=C)C=C1.CC1=CC(CC=C)=CC=C1O MVMVVEIJWOKMLH-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010013554 Diverticulum Diseases 0.000 description 1
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 238000002169 hydrotherapy Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 210000001599 sigmoid colon Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410237818.5A CN104000934B (zh) | 2014-06-01 | 2014-06-01 | 一种低溶点灌肠咖啡组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410237818.5A CN104000934B (zh) | 2014-06-01 | 2014-06-01 | 一种低溶点灌肠咖啡组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104000934A CN104000934A (zh) | 2014-08-27 |
CN104000934B true CN104000934B (zh) | 2016-11-23 |
Family
ID=51362023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410237818.5A Active CN104000934B (zh) | 2014-06-01 | 2014-06-01 | 一种低溶点灌肠咖啡组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104000934B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115444892A (zh) * | 2017-08-28 | 2022-12-09 | 郴州心境茶业生物科技有限公司 | 一种肠疗养生料的配方及其使用方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103478371A (zh) * | 2013-04-29 | 2014-01-01 | 保山锦庆热作科技有限公司 | 低温灌肠咖啡 |
CN103768198A (zh) * | 2013-05-01 | 2014-05-07 | 保山锦庆热作科技有限公司 | 咖啡灌肠液的制作方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005187394A (ja) * | 2003-12-25 | 2005-07-14 | Kanebo Ltd | 漢方生薬エキス含有組成物及びそれを含有する製剤 |
-
2014
- 2014-06-01 CN CN201410237818.5A patent/CN104000934B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103478371A (zh) * | 2013-04-29 | 2014-01-01 | 保山锦庆热作科技有限公司 | 低温灌肠咖啡 |
CN103768198A (zh) * | 2013-05-01 | 2014-05-07 | 保山锦庆热作科技有限公司 | 咖啡灌肠液的制作方法 |
Non-Patent Citations (2)
Title |
---|
夏枯草治疗盆腔炎;郭蕾;《中医杂志》;19990731;第40卷(第7期);第391-392页 * |
慢性溃疡性结肠炎中药灌肠治疗的疗效观察与护理;王淑华等;《中华现代护理学杂志》;20091231;第6卷(第1期);第17-19页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104000934A (zh) | 2014-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101869626B (zh) | 中药复方制剂舒阴液及其制备与应用 | |
CN104173937A (zh) | 一种疏肝利胆的中药组合物及其应用 | |
CN102188685B (zh) | 一种治疗腹泻型肠易激综合征的中药外敷散剂及其制备方法 | |
CN104096032A (zh) | 一种治疗腹泻的石榴皮中药汤剂及其制备方法 | |
CN104000934B (zh) | 一种低溶点灌肠咖啡组合物 | |
CN104547048A (zh) | 一种预防并治疗小儿手足口病的中药复方制剂及其制备方法 | |
CN101804171A (zh) | 一种治疗胃癌的药物 | |
CN105012521A (zh) | 一种治疗前列腺的中药组合物 | |
CN104189690A (zh) | 用于解除男性前列腺炎症和增生的中药制剂 | |
CN102755623A (zh) | 一种治疗急性胃肠炎的药物及其制备方法 | |
CN102178866A (zh) | 用于气郁、血瘀体质人袪湿活血、软坚散结的中药制剂及其制备方法和应用 | |
CN105617275A (zh) | 一种用于治疗急性膀胱炎的中药制剂及制备方法 | |
CN102210769A (zh) | 一种治疗前列腺炎的中药组合物 | |
CN104840896A (zh) | 一种治疗胆囊炎的中药及制备方法 | |
CN104027700A (zh) | 一种治疗慢性前列腺炎的中药组合物及其制备方法 | |
CN104324201A (zh) | 治疗泌尿系感染的中药制剂及制备方法 | |
CN103989836A (zh) | 一种治疗阑尾炎的中药制剂及制备方法 | |
CN104127753A (zh) | 一种治疗痛风性关节炎的中药袋泡茶及其制备方法 | |
CN103877484A (zh) | 一种治疗慢性肠炎的中药口服液 | |
CN103989924A (zh) | 一种治疗老年性便秘的中药组合物灌肠剂 | |
CN103735710A (zh) | 用于治疗奶牛隐性乳房炎的中药组合物及其制备方法 | |
CN105770273A (zh) | 一种治疗小儿消化不良的汤剂药物及其制备方法 | |
CN103977349A (zh) | 一种治疗肥胖症的中药灌肠剂 | |
CN104873857A (zh) | 一种治疗消化道感染的中药 | |
CN104984305B (zh) | 一种治疗慢性胆囊炎的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Jiang Xi Inventor after: Niu Yunfei Inventor after: Shen Ting Inventor before: Shen Ting |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160923 Address after: Qingpu District of Shanghai city in 201703 Zhao Zhen Huqingping No. 3797 Applicant after: Shanghai Handing Household Electrical Appliance Co., Ltd. Address before: 200051, room 2, building 750, 224 West Zhongshan Road, Shanghai, Changning District Applicant before: There is vigorous and graceful health referral centre in Shanghai |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180209 Address after: 201306 Shanghai city Pudong New Area mud Town Road No. 979 Building 2 Hon Patentee after: Shanghai Dianming Medical Technology Co., Ltd. Address before: Qingpu District of Shanghai city in 201703 Zhao Zhen Huqingping No. 3797 Patentee before: Shanghai Handing Household Electrical Appliance Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210322 Address after: Zone A, 2nd Floor, Building 9, 258 Zhenying Road, Qingpu District, Shanghai, 201712 Patentee after: Shanghai Dingming Medical Devices Co.,Ltd. Address before: 201306 2, building 979, Yun Han Road, mud town, Pudong New Area, Shanghai Patentee before: SHANGHAI DIANMING MEDICAL TECHNOLOGY Co.,Ltd. |